ClinicalTrials.gg
RecruitingNCT04856241Prep-to-PlayUpdated Oct 11, 2023

Making Football Safer for Women: Implementing an Injury Prevention Program

An interventional study of Coaching and Peer support in Anterior Cruciate Ligament Injuries, Concussion, Brain and Musculoskeletal Injury, sponsored by La Trobe University. Recruiting at 1 site in Australia. Open to female participants aged 14 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-11.

Sponsored by La Trobe University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 6 months ago, but the record still lists the study as recruiting.
  • Started Apr 2021; still recruiting 5 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
2,600
Allocation
Randomized
Ages
14 Years and older
Sex
Female
01

Study summary

The aim of this study is to determine how we can best support coaches to implement an injury prevention (IP) program (Prep-to-Play) in female community Australian Football. We will recruit at least 140 female community football teams from 15 different football leagues in Victoria, Australia. Teams will be competing in U16, U17, U18, U19 or open womens competitions. We will train and support coaches to implement the IP program and evaluate the effects of the IP program on injuries across two football seasons.

Read the detailed description

Primary Aim: To compare the impact of supported and unsupported implementation strategies on the use of an IP program (Prep-to-Play) in female community Australian Football.

Secondary aims are to:

  1. Evaluate the effects of supported implementation of Prep-to-Play on injury risk reduction.
  2. Identify barriers and enablers to sustainability of the Prep-to-Play implementation model, and develop clear recommendations for a future, sustainable national roll out of Prep-to-Play.
  3. Evaluate the cost-effectiveness of Prep-to-Play.

Primary hypothesis

The primary hypothesis is that supported implementation will result in increased use of Prep-to-Play in female community Australian Football compared to unsupported implementation.

Secondary hypotheses

The secondary hypotheses are that the supported implementation of Prep-to-Play will:

  • result in a reduction of anterior cruciate ligament (ACL) injuries in females participating in community Australian Football;
  • result in a reduction of other musculoskeletal injuries and concussion among females participating in community Australian Football;
  • be more cost-effective than the unsupported implementation.
02

Conditions studied

  • Anterior Cruciate Ligament Injuries
  • Concussion, Brain
  • Musculoskeletal Injury

Keywords

  • injury prevention
  • implementation
  • football
  • female
03

In context

Anterior Cruciate Ligament Injuries

625 studies on the registry are indexed under Anterior Cruciate Ligament Injuries; 192 are open to participants now.

This study's planned enrollment of 2,600 is above the median of 56 across 458 interventional studies indexed under Anterior Cruciate Ligament Injuries.

Browse Anterior Cruciate Ligament Injuries studies →

Lead sponsor

La Trobe University is the lead sponsor of 8 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Coach consents to be trained and to implement Prep-to-Play
  • Team includes players aged 13 years and above registered to play community football
  • The team trains at least once per week in addition to match-play
  • Coach has at least Level I coach accreditation (or enrolled to be accredited in 2021)

Exclusion criteria

Exclusion Criteria:

  • Inability to understand written English
  • Players aged less than 13 years
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
2,600 participants (estimated)

Study arms

  • Experimental
    Supported Implementation (Intervention)

    Our supported implementation approach is designed to improve uptake of Prep-to-Play. The Prep-to-Play program consists of four components: dynamic warm-up, strength training, football fundamentals, and education. At the start of the intervention period, Prep-to-Play Physiotherapists will conduct a 3-hour workshop for coaches and influential players. Ongoing support will be provided via a range of strategies. Prep-to-Play Physiotherapists will attend training (two times) during and immediately post implementation to provide coaches with support (feedback on missing components, player technique, questions). Monthly Coaches Shed; Online drop-in session with education component to meet other coaches (peer support \& networking) and ask questions. Refresher workshops will be run in pre-season 2022 for the teams who have received the intervention in 2021.

    Other: Coaching · Other: Peer support · Other: Educational materials

  • Active comparator
    Unsupported implementation (Control)

    The unsupported implementation arm will be "usual care". Access to the Prep-to-Play resources, including videos, downloadable manuals and posters, are freely available to coaches online. The online resources incorporate the same four concepts as described in the supported implementation - dynamic warm-up, strength exercises, football fundamentals, and education. In the control arm, no additional resources, education, or support will be provided.

    Other: Educational materials

Interventions

  • OtherCoaching

    Physiotherapists (trained by the research team) train the coaches to deliver Prep-to-Play. The Physiotherapists will also provide face-to-face one-to-one support to each coach at their team's training session (two visits), with all their players.

  • OtherPeer support

    Coaches shed. Coaches provide each other with support and ideas. Strategies to overcome barriers and motivate players.

  • OtherEducational materials

    Prep-to-Play program resources are available online for coaches and players to view

06

What researchers measure

Primary outcomes

  1. Use of Prep-to-Play (Primary outcome)

    Use of Prep-to-Play will be calculated as the proportion of all possible team sessions (training and games) where Prep-to-Play essential components were completed. The primary outcome assessor will be the Team Designate (i.e., nominated team manager, or team representative) who will record (via the Smartabase App or website) whether essential components of Prep-to-Play were completed at each training session and games. In addition to the Team Designate, Prep-to-Play Observers (research assistants blinded to randomisation) will make five random visits (≥one prior to the intervention period and ≥two after the intervention period) to observe the execution of Prep-to-Play in order to validate team use data from the Team Designates.

    Time frame: 18 months

Secondary outcomes

  1. Number of players with an ACL injury (Secondary outcome)

    The primary injuries of interest are ACL injuries and concussion. An ACL/all other injuries will be defined as any injury occurring during a football match or training that results in a player being unable to return to the field of play for that match, or missing at least one match. ACL injury definition • Ruptured ACL is confirmed by clinical examination, with or without magnetic resonance imaging or surgery. Injury data will be collected via two methods to minimise missing data: (i) sports trainer; (ii) direct from player

    Time frame: 18 months

  2. Number of players with a concussion (Secondary outcome)

    A head injury will be defined as any injury to the head region occurring during a football match or training, regardless of time loss. Concussion definition • Direct or indirect impact to the head resulting in loss of consciousness and/or any of the following clinical symptoms (memory loss, headache, dizziness, nausea, difficulty concentrating, feeling like being in a fog, feeling not quite right). Injury data will be collected via two methods to minimise missing data: (i) sports trainer; (ii) direct from player

    Time frame: 18 months

  3. Number of player hours (training and match)

    The number of training and match hours for each team will be collected, and reported at a team-level. Weekly team match exposure will be estimated from the number of matches played, multiplied by the number of players in each match (publicly available registry), and the match length (junior: 1 hour, senior: 1.5 hours). Weekly team training exposure will be estimated using the number and duration of football training sessions completed (reported by team designates), multiplied by the average number of players at training (reported by independent observers on five occasions).

    Time frame: 18 months

  4. Healthcare utilisation

    Healthcare use for players sustaining a knee or head injury will be obtained by the blinded research officer to estimate healthcare costs of sustaining an injury to inform health economic evaluation.

    Time frame: 18 months

07

Study locations

1 of 1 sites recruiting
  • Community Australian Football Leagues
    Melbourne, Victoria 3121, Australia
    Recruiting
08

References and documents

Publications

  • Patterson BE, Donaldson A, Cowan SM, King MG, Barton CG, McPhail SM, Hagglund M, White NM, Lannin NA, Ackerman IN, Dowsey MM, Hemming K, Makdissi M, Culvenor AG, Mosler AB, Bruder AM, Choong J, Livingstone N, Elliott RK, Nikolic A, Fitzpatrick J, Crain J, Haberfield MJ, Roughead EA, Birch E, Lampard SJ, Bonello C, Chilman KL, Crossley KM. Evaluation of an injury prevention programme (Prep-to-Play) in women and girls playing Australian Football: design of a pragmatic, type III, hybrid implementation-effectiveness, stepped-wedge, cluster randomised controlled trial. BMJ Open. 2022 Sep 14;12(9):e062483. doi: 10.1136/bmjopen-2022-062483. PubMed 36104145 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2021 (actual). Primary completion is estimated for Apr 2025, 47 months after the start.

Of 277 non-industry interventional studies with no phase under Anterior Cruciate Ligament Injuries, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 70. This study's planned 47 months is above that.

Counting every sponsor, half of 286 studies reached it within 30 months; a quarter within 14 and three quarters within 70.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 14, 2021
First posted
Apr 23, 2021
StartActual
Apr 22, 2021
Primary completionEst.
Apr 13, 2025
CompletionEst.
Dec 21, 2025
Last update
Oct 11, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 11, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04856241
Lead sponsor
La Trobe University
Responsible party
Sponsor
First posted
Apr 23, 2021
Start date
Apr 22, 2021
Primary completion
Apr 13, 2025 (estimated)
Completion
Dec 21, 2025 (estimated)
Last update
Oct 11, 2023

Study contacts

Sallie Cowan, PhD, PT
Contact
Sallie.Cowan@latrobe.edu.au
+61 (03) 94793483
Brooke Patterson, PhD, PT
Contact
B.Patterson@latrobe.edu.au
+61 (03) 94793483
Kay Crossley, PhD, PT
principal investigator · La Trobe University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion